Lipoxygenase-modified Ru-bpy/graphene oxide: Electrochemical biosensor for on-farm monitoring of non-esterified fatty acid

Point-of-Care Diagnostics for Farm Animal Diseases: From Biosensors to Integrated Lab-on-Chip Devices

Zoonoses and animal diseases threaten human health and livestock biosecurity and productivity. Currently, laboratory confirmation of animal disease outbreaks requires centralized laboratories and trained personnel; it is expensive and time-consuming, and it often does not coincide with the onset or progress of diseases. Point-of-care (POC) diagnostics are rapid, simple, and cost-effective devices and tests, that can be directly applied on field for the detection of animal pathogens. The development of POC diagnostics for use in human medicine has displayed remarkable progress. Nevertheless, animal POC testing has not yet unfolded its full potential. POC devices and tests for animal diseases face many challenges, such as insufficient validation, simplicity, and portability. Emerging technologies and advanced materials are expected to overcome some of these challenges and could popularize animal POC testing. This review aims to: (i) present the main concepts and formats of POC devices and tests, such as lateral flow assays and lab-on-chip devices; (ii) summarize the mode of operation and recent advances in biosensor and POC devices for the detection of farm animal diseases; (iii) present some of the regulatory aspects of POC commercialization in the EU, USA, and Japan; and (iv) summarize the challenges and future perspectives of animal POC testing.

Nanomaterials-assisted metabolic analysis toward in vitro diagnostics

In vitro diagnostics (IVD) has played an indispensable role in healthcare system by providing necessary information to indicate disease condition and guide therapeutic decision. Metabolic analysis can be the primary choice to facilitate the IVD since it characterizes the downstream metabolites and offers real-time feedback of the human body. Nanomaterials with well-designed composition and nanostructure have been developed for the construction of high-performance detection platforms toward metabolic analysis. Herein, we summarize the recent progress of nanomaterials-assisted metabolic analysis and the related applications in IVD. We first introduce the important role that nanomaterials play in metabolic analysis when coupled with different detection platforms, including electrochemical sensors, optical spectrometry, and mass spectrometry. We further highlight the nanomaterials-assisted metabolic analysis toward IVD applications, from the perspectives of both the targeted biomarker quantitation and untargeted fingerprint extraction. This review provides fundamental insights into the function of nanomaterials in metabolic analysis, thus facilitating the design of next-generation diagnostic devices in clinical practice.

Hydrophilic graphene oxide-dopamine-cationic cellulose composites and their applications in N-Glycopeptides enrichment

Glycosylation is one of the most important post-translational modifications of proteins, and plays an important role in the structure and function of proteins. However, due to the diversity of glycopeptide forms and their low abundance, it is extraordinarily challenging to capture and separate glycopeptides with high selectivity from complex biological samples with mass spectrometric analysis. Here, we synthesized a new type of hydrophilic composite based on electrostatic interactions, which has been proven to be effective in immobilizing cationic cellulose on graphene oxide-dopamine carriers (expressed as GO-DA-JR), for highly specific enrichment of N-glycopeptides. The introduction of cationic cellulose provides not only a perfect surface charge for the composite but also a greater ability to enrich glycosylated peptides. Thirty-two glycopeptides from human serum immunoglobulin G (IgG) tryptic digests were observed with a greatly improved signal-to-noise ratio (S/N) and also presented high performance in anti-interfering enrichment of glycopeptides from complex samples containing 100-fold bovine serum albumin tryptic digests. In addition, GO-DA-JR has higher sensitivity (1 fmol/μL IgG) and better enrichment capacity (up to 150 mg/g). Moreover, the results of glycopeptide enrichment and glycosylation analysis from human serum also show egood enrichment selectivity from real biological samples. This work exhibits high selectivity, high sensitivity, good stability and operability, indicating its potential for applications of glycopeptides enrichment in post-translational modification proteomics.

Studies Towards the Development of a Novel, Screen-Printed Carbon-Based, Biosensor for the Measurement of Polyunsaturated Fatty Acids

This paper describes the design, development and characterisation of an electrochemical biosensor for the measurement of linoleic and α-linolenic acid, as representative free polyunsaturated fatty acids (PUFAs), that may be implicated in food safety and food quality. Initial cyclic voltammetric studies were performed with solutions that contained enzyme-generated hydroperoxides of the two PUFAs. These were examined with plain screen-printed carbon electrodes (SPCEs) and screen-printed carbon electrodes containing the electrocatalyst cobalt phthalocyanine (CoPC). The electrocatalytic oxidation peaks obtained with the latter occurred at potentials about 300 mV lower than the those obtained by direct oxidation with the plain SPCEs and were better defined; as these attributes would lead to better selectivity and sensitivity for fatty acid determinations, the CoPC-SPCEs were used in the fabrication of amperometric biosensors. The enzyme lipoxygenase (LOX) was immobilised on the surface of these devices using the crosslinking agent glutaraldehyde. These biosensors were optimised for the measurement of linoleic and α-linolenic acid using amperometry in stirred solution; the optimum conditions were deduced by studying the effect of enzyme loading, pH and temperature on the amperometric responses. These responses were examined over the concentration range 2.0 to 20 µM and the results indicated that the following conditions were optimal: LOX loading 15 units; pH 8.0; temperature 37 °C. Low concentration calibration studies were performed with the two PUFAs and it was shown that the steady state currents were linear between 0.2 and 10 µM for linoleic acid and 0.2 and 10 µM for α-linolenic acid; the detection limits were 24 and 100 nM, respectively. The precision (coefficient of variation, n = 6) was 5.3% for α-linoleic acid and 3.3% for linoleic acid, which were calculated from the steady state current following additions (n = 6) of 0.2 µM PUFA. These results demonstrate that the novel amperometric biosensor holds promise for determining whether foods contain acceptable levels of free fatty acids.

Influence of Three Commercial Graphene Derivatives on the Catalytic Properties of a Lactobacillus plantarum α-l-Rhamnosidase When Used as Immobilization Matrices

The modification of carbon nanomaterials with biological molecules paves the way toward their use in biomedical and biotechnological applications, such as next-generation biocatalytic processes, development of biosensors, implantable electronic devices, or drug delivery. In this study, different commercial graphene derivatives, namely, monolayer graphene oxide (GO), graphene oxide nanocolloids (GOCs), and polycarboxylate-functionalized graphene nanoplatelets (GNs), were compared as biomolecule carrier matrices. Detailed spectroscopic analyses showed that GO and GOC were similar in composition and functional group content and very different from GN, whereas divergent morphological characteristics were observed for each nanomaterial through microscopy analyses. The commercial α-l-rhamnosidase RhaB1 from the probiotic bacterium Lactobacillus plantarum, selected as a model biomolecule for its relevant role in the pharma and food industries, was directly immobilized on the different materials. The binding efficiency and biochemical properties of RhaB1-GO, RhaB1-GOC, and RhaB1-GN composites were analyzed. RhaB1-GO and RhaB1-GOC showed high binding efficiency, whereas the enzyme loading on GN, not tested in previous enzyme immobilization studies, was low. The enzyme showed contrasting changes when immobilized on the different material supports. The effect of pH on the activity of the three RhaB1-immobilized versions was similar to that observed for the free enzyme, whereas the activity-temperature profiles and the response to the presence of inhibitors varied significantly between the RhaB1 versions. In addition, the apparent K_m for the immobilized and soluble enzymes did not change. Finally, the free RhaB1 and the immobilized enzyme in GOC showed the best storage and reutilization stability, keeping most of their initial activity after 8 weeks of storage at 4 °C and 10 reutilization cycles, respectively. This study shows, for the first time, that distinct commercial graphene derivatives can influence differently the catalytic properties of an enzyme during its immobilization.

A highly efficient 2D exfoliated metal dichalcogenide for the on-farm rapid monitoring of non-esterified fatty acids

Liquid phase exfoliation of 2D MoS₂and bioconjugation with NEFA antibodies to develop a biointerface over the SPE.

Graphene-based multiplexed disposable electrochemical biosensor for rapid on-farm monitoring of NEFA and βHBA dairy biomarkers

Label-free assay using electrodeposited antibody-conjugated graphene biointerface for dual detection of NEFA and βHBA from dairy cow blood samples.

Simultaneous electrochemical detection of Cd(II), Pb(II), As(III) and Hg(II) ions using ruthenium(II)-textured graphene oxide nanocomposite

Simultaneous determination of Cd(II), Pb(II), As(III) and Hg(II) metal ions was carried out based on the synergistic effect of graphene oxide (GO) textured with redox active ruthenium(II) bipyridine complex ([Ru(bpy)₃]²⁺). [Ru(bpy)₃]²⁺-GO nanocomposite on the modified gold (Au) electrode acts as an electrocatalyst and favours the sensitive and selective detection of metal ions. Also, it exhibited an enhanced electron transfer rate with a low solution resistance examined by cyclic voltammetry and impedance analysis. The inherent electrochemical and electrocatalytic behaviours of [Ru(bpy)₃]²⁺-GO on gold electrode were demonstrated for simultaneous detection of heavy metal ions in water matrix. The proposed sensor exhibited a higher sensitivity towards Cd(II), Pb(II), As(III) and Hg(II) metal ions with a lowest detection limit of 2.8, 1.41, 2.3 and 1.6nM respectively. The observed detection limits were less than the World Health Organization standards and hence the developed sensor can be deployed for detecting heavy metal ions in water bodies. Simultaneous electrochemical detection of heavy metal ions in river and tap water was carried out using the developed sensor and the observed results were validated with atomic absorption spectroscopy.

In vivo pharmacokinetics, biodistribution and the anti-tumor effect of cyclic RGD-modified doxorubicin-loaded polymers in tumor-bearing mice

In our previous study, we successfully produced and characterized a multifunctional drug delivery system with doxorubicin (RC/GO/DOX), which was based on graphene oxide (GO) and cyclic RGD-modified chitosan (RC). Its characteristics include: pH-responsiveness, active targeting of hepatocarcinoma cells, and efficient loading with controlled drug release. Here, we report the pharmacokinetics, biodistribution, and anti-tumor efficacy of RC/GO/DOX polymers in tumor-bearing nude mice. The objective of this study is to assess its targeting potential for tumors. Pharmacokinetic and biodistribution profiles demonstrated that tumor accumulation of RC/GO/DOX polymers was almost three times higher than the others, highlighting the efficacy of the active targeting strategy. Furthermore, the tumor inhibition rate of RC/GO/DOX polymers was 56.64%, 2.09 and 2.93 times higher than that of CS/GO/DOX polymers (without modification) and the DOX solution, respectively. Anti-tumor efficacy results indicated that the tumor growth was better controlled by RC/GO/DOX polymers than the others. Hematoxylin and eosin (H&E) staining showed remarkable changes in tumor histology. Compared with the saline group, the tumor section from the RC/GO/DOX group revealed a marked increase in the quantity of apoptotic and necrotic cells, and a reduction in the quantity of the blood vessels. Together, these studies show that this new system could be regarded as a suitable form of DOX-based treatment of the hepatocellular carcinoma.